Stock Report

All about this stock under one free report Last Updated: 02-Sep-2026

Stock Rating

Is this stock worth it? Our ratings reveal the truth.

Wealth Insight New Issue

This month’s issue could change how you invest, read now.

Recently Viewed

Clear All

Innate Pharma S.A. ADS - ADR Key Ratios

Stock Card factsheet share-fund-plan-icon

$2.12

up-down-arrow $-0.05 (-2.30%)

As on 01-Sep-2026 16:00EDT

Market cap

info icon

$248 Mln

Revenue (TTM)

info icon

$66 Mln

P/E Ratio

info icon

--

P/B Ratio

info icon

20.1

Div. Yield

info icon

0 %

Key Ratios and Highlights

Growth Score (%) Quarterly Annual (TTM)
Particulars QoQ YoY 1-Year 3-Years 5-Years
Revenue 0.00 -851.09 -77.92 -63.58 -47.48
EBIT 0.00 -38.89 0.34 4.92 -314.27
Net Profit 0.00 -11.82 0.59 4.88 4.25
EPS 0.00 0.85 12.06 7.94 5.97
Book Value -- -- -- -- --
Key Ratios (%) Average Annual (TTM)
Particulars3-Years5-YearsDec-25Dec-24Dec-23
EBIT-Margin info -716.52-528.89-1,748.73-387.49-13.35
Net Margin info ----------
Return on equity info 195.8695.11764.76-162.91-14.28
Return on Capital info -108.30-80.81-241.67-75.17-8.04
Return on Assets info -31.71-27.59-56.61-34.57-3.95
Debt to Equity (x) info -----1.043.510.77

Profitability

View Detailed Peer Comparison

ROCE

-241.67

--

Earning before interest and taxes / (Average net worth + Average total Debt) * 100

Company Name
Dec-25
Dec-24
Dec-23
Dec-22
Dec-21
Innate Pharma S.A. ADS - ADR
-241.67
-75.17
-8.04
-46.84
-32.32
Peer Median
--
--
--
--
--
ROE

764.76

--

Profit after tax / Average Net worth * 100

Company Name
Dec-25
Dec-24
Dec-23
Dec-22
Dec-21
Innate Pharma S.A. ADS - ADR
764.76
-162.91
-14.28
-71.91
-40.10
Peer Median
--
--
--
--
--
ROA

-56.61

--

Profit after tax / Average Total assets * 100

Company Name
Dec-25
Dec-24
Dec-23
Dec-22
Dec-21
Innate Pharma S.A. ADS - ADR
-56.61
-34.57
-3.95
-24.45
-18.37
Peer Median
--
--
--
--
--
EBIT Margin

-1,748.73

--

Operating profit (EBIT) / Net Sales * 100

Company Name
Dec-25
Dec-24
Dec-23
Dec-22
Dec-21
Innate Pharma S.A. ADS - ADR
-1,748.73
-387.49
-13.35
-100.02
-394.86
Peer Median
--
--
--
--
--
Net Margin

-1,764.51

--

Net profit / Total Income (Net sales plus other income) * 100

Company Name
Dec-25
Dec-24
Dec-23
Dec-22
Dec-21
Innate Pharma S.A. ADS - ADR
-1,764.51
-391.97
-14.59
-100.74
-436.01
Peer Median
--
--
--
--
--

Growth

View Detailed Peer Comparison

Revenue Growth

-0.78

--

Year on year growth in net sales

Company Name
Dec-25
Dec-24
Dec-23
Dec-22
Dec-21
Innate Pharma S.A. ADS - ADR
-0.78
-0.76
-0.10
3.76
-0.83
Peer Median
--
--
--
--
--
EBIT Growth

0.34

--

Year on year growth in operating profit (EBIT)

Company Name
Dec-25
Dec-24
Dec-23
Dec-22
Dec-21
Innate Pharma S.A. ADS - ADR
0.34
-605.70
87.99
-20.61
-4,532.34
Peer Median
--
--
--
--
--
Net Profit Growth

0.59

--

Year on year growth in profit after tax

Company Name
Dec-25
Dec-24
Dec-23
Dec-22
Dec-21
Innate Pharma S.A. ADS - ADR
0.59
-553.51
86.97
-10.02
17.47
Peer Median
--
--
--
--
--
EPS Growth

0.12

--

Year on year growth in earnings per share

Company Name
Dec-25
Dec-24
Dec-23
Dec-22
Dec-21
Innate Pharma S.A. ADS - ADR
0.12
-5.51
0.87
-0.09
0.18
Peer Median
--
--
--
--
--

Solvency

View Detailed Peer Comparison

Debt to Equity

-1.04

--

Total debt / Net worth

Company Name
Dec-25
Dec-24
Dec-23
Dec-22
Dec-21
Innate Pharma S.A. ADS - ADR
-1.04
3.51
0.77
0.78
0.41
Peer Median
--
--
--
--
--
Short term debt to equity ratio

-0.41

--

(Short term borrowings / Net worth)

Company Name
Dec-25
Dec-24
Dec-23
Dec-22
Dec-21
Innate Pharma S.A. ADS - ADR
-0.41
0.99
0.17
0.04
0.29
Peer Median
--
--
--
--
--
Current Ratio

1.27

--

Current Assets / Current Liabilities and Provisions

Company Name
Dec-25
Dec-24
Dec-23
Dec-22
Dec-21
Innate Pharma S.A. ADS - ADR
1.27
2.60
3.73
3.38
1.73
Peer Median
--
--
--
--
--
Quick Ratio

--

--

(Current Assets - Inventory) / Current Liabilities and Provisions

Company Name
Dec-25
Dec-24
Dec-23
Dec-22
Dec-21
Innate Pharma S.A. ADS - ADR
--
--
3.82
3.38
1.79
Peer Median
--
--
--
--
--
Interest Coverage

-110.77

--

Earning before interest and taxes (EBIT) / Interest Expenses

Company Name
Dec-25
Dec-24
Dec-23
Dec-22
Dec-21
Innate Pharma S.A. ADS - ADR
-110.77
-86.40
-10.83
-200.29
-153.29
Peer Median
--
--
--
--
--

Operating Efficiency

View Detailed Peer Comparison

Debtors to sales

273.05

--

Debtors outstanding / Net Sales * 100

Company Name
Dec-25
Dec-24
Dec-23
Dec-22
Dec-21
Innate Pharma S.A. ADS - ADR
273.05
13.02
89.57
5.45
13.71
Peer Median
--
--
--
--
--
Asset Turnover

0.03

--

Sales / Average Total Assets

Company Name
Dec-25
Dec-24
Dec-23
Dec-22
Dec-21
Innate Pharma S.A. ADS - ADR
0.03
0.09
0.27
0.24
0.04
Peer Median
--
--
--
--
--
Receivable days

606.33

--

Average Debtors / Sales * 365

Company Name
Dec-25
Dec-24
Dec-23
Dec-22
Dec-21
Innate Pharma S.A. ADS - ADR
606.33
696.47
174.63
15.20
195.80
Peer Median
--
--
--
--
--
Inventory Days

--

--

Average Inventory / Sales * 365

Company Name
Dec-25
Dec-24
Dec-23
Dec-22
Dec-21
Innate Pharma S.A. ADS - ADR
--
-23.71
-11.01
-17.49
-6.47
Peer Median
--
--
--
--
--
Payable days

--

--

Average Creditors / Cost of goods sold * 365

Company Name
Dec-25
Dec-24
Dec-23
Dec-22
Dec-21
Innate Pharma S.A. ADS - ADR
--
57.91
72.42
100.34
137.77
Peer Median
--
--
--
--
--
Cash Conversion Cycle

--

--

Receivable Days + Inventory Days - Payable Days

Company Name
Dec-25
Dec-24
Dec-23
Dec-22
Dec-21
Innate Pharma S.A. ADS - ADR
--
614.84
91.20
-102.63
51.57
Peer Median
--
--
--
--
--
loading...
loading...